Paper39192579
Akkermansia muciniphila: A promising probiotic against inflammation and metabolic disorders.
Zhao Y and 8 others. Virulence, 2024. Cited by 110 papers, by iCite.
Cite this record
ConductScience Library. Akkermansia muciniphila: A promising probiotic against inflammation and metabolic disorders. Papers, record 39192579. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39192579
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Akkermansia muciniphila: A promising probiotic against inflammation and metabolic disorders.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Probiotics | Major topic |
| Akkermansia | Major topic |
| Gastrointestinal Microbiome | Major topic |
| Inflammation | Major topic |
| Metabolic Diseases | Major topic |
| Humans | |
| Animals | |
| Diabetes Mellitus, Type 2 | |
| Obesity | |
| Verrucomicrobia |
Source PubMed
References177
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34085773 | Decreased Abundance of Akkermansia muciniphila Leads to the Impairment of Insulin Secretion and Glucose Homeostasis in Lean Type 2 Diabetes. | Adv Sci (Weinh) | 2021 | https://conductscience.org/library/papers/34085773 | PubMed |
| 2 | 36275453 | Quantitative real-time PCR analysis of bacterial biomarkers enable fast and accurate monitoring in inflammatory bowel disease. | PeerJ | 2022 | https://conductscience.org/library/papers/36275453 | PubMed |
| 3 | 34742442 | β-Glucan-triggered Akkermansia muciniphila expansion facilitates the expulsion of intestinal helminth via TLR2 in mice. | Carbohydr Polym | 2022 | https://conductscience.org/library/papers/34742442 | PubMed |
| 4 | 33622853 | Impaired Intestinal Akkermansia muciniphila and Aryl Hydrocarbon Receptor Ligands Contribute to Nonalcoholic Fatty Liver Disease in Mice. | mSystems | 2021 | https://conductscience.org/library/papers/33622853 | PubMed |
| 5 | 33139845 | Self and microbiota-derived epitopes induce CD4+ T cell anergy and conversion into CD4+Foxp3+ regulatory cells. | Mucosal Immunol | 2021 | https://conductscience.org/library/papers/33139845 | PubMed |
| 6 | 37787527 | Akkermansia muciniphila supplementation improves glucose tolerance in intestinal Ffar4 knockout mice during the daily light to dark transition. | mSystems | 2023 | https://conductscience.org/library/papers/37787527 | PubMed |
| 7 | 27892954 | A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. | Nat Med | 2017 | https://conductscience.org/library/papers/27892954 | PubMed |
| 8 | 30410033 | Multiple sclerosis. | Nat Rev Dis Primers | 2018 | https://conductscience.org/library/papers/30410033 | PubMed |
| 9 | 35613313 | Revisiting the role of Akkermansia muciniphila as a therapeutic bacterium. | Gut Microbes | 2022 | https://conductscience.org/library/papers/35613313 | PubMed |
| 10 | 36835309 | Akkermansia muciniphila as a Next-Generation Probiotic in Modulating Human Metabolic Homeostasis and Disease Progression: A Role Mediated by Gut-Liver-Brain Axes? | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36835309 | PubMed |
| 11 | 28550049 | Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease. | Gut | 2018 | https://conductscience.org/library/papers/28550049 | PubMed |
| 12 | 38571945 | Akkermansia muciniphila: a potential candidate for ameliorating metabolic diseases. | Front Immunol | 2024 | https://conductscience.org/library/papers/38571945 | PubMed |
| 13 | 23665276 | Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. | Gastroenterology | 2013 | https://conductscience.org/library/papers/23665276 | PubMed |
| 14 | 24414342 | Immunological alteration and changes of gut microbiota after dextran sulfate sodium (DSS) administration in mice. | Clin Exp Med | 2015 | https://conductscience.org/library/papers/24414342 | PubMed |
| 15 | 29018410 | Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila. | Front Microbiol | 2017 | https://conductscience.org/library/papers/29018410 | PubMed |
| 16 | 36256871 | The opportunistic nature of gut commensal microbiota. | Crit Rev Microbiol | 2023 | https://conductscience.org/library/papers/36256871 | PubMed |
| 17 | 38128750 | Human gut microbiota from hepatitis B virus-infected individuals is associated with reduced triglyceride level in mice: faecal transplantation study. | Microbes Infect | 2024 | https://conductscience.org/library/papers/38128750 | PubMed |
| 18 | 33232646 | Gut Microbiota and Serum Biomarker Analyses in Obese Patients Diagnosed with Diabetes and Hypothyroid Disorder. | Metab Syndr Relat Disord | 2021 | https://conductscience.org/library/papers/33232646 | PubMed |
| 19 | 27571978 | The microenvironment of injured murine gut elicits a local pro-restitutive microbiota. | Nat Microbiol | 2016 | https://conductscience.org/library/papers/27571978 | PubMed |
| 20 | 38263790 | Akkermansia muciniphila improves chronic colitis-induced enteric neuroinflammation in mice. | Neurogastroenterol Motil | 2024 | https://conductscience.org/library/papers/38263790 | PubMed |
Cited by80
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 110 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42908011 | Decoding metabolic diseases through bacterial extracellular vesicles: mechanisms, diagnostics, and therapeutics. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42908011 | PubMed |
| 42890816 | Akkermansia muciniphila enhances chicken resistance to infectious bronchitis virus by boosting GABA synthesis and suppressing the NF-κB inflammatory pathway. | IMetaOmics | 2026 | https://conductscience.org/library/papers/42890816 | PubMed |
| 42890572 | Shenze shugan capsules alleviate alcoholic liver injury in association with modulation of the TGF-β/smad4 signaling pathway. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42890572 | PubMed |
| 42846992 | Longitudinal dynamics of the gut microbiome during methamphetamine addiction and abstinence. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42846992 | PubMed |
| 42787553 | A data-driven universal gut microbiome health assessment: a machine learning framework trained on large metagenomic data. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42787553 | PubMed |
| 42780744 | Pathogen distribution, antimicrobial resistance, and gut microbiota dysbiosis in patients with cirrhosis complicated by infection in northwestern China. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42780744 | PubMed |
| 42739036 | The Gut Microbiome as a Mechanistic Link Between the Planetary Health Diet and Healthy Aging. | Nutrients | 2026 | https://conductscience.org/library/papers/42739036 | PubMed |
| 42738964 | Probiotic-Herb-Peptide Combined Formula Alleviates Alcoholic Liver Damage Associated with Modulation of the Gut-Liver Axis and Ferroptosis. | Nutrients | 2026 | https://conductscience.org/library/papers/42738964 | PubMed |
| 42737321 | Metabolic Profile and Dynamic Characteristics of Ziziphi Spinosae Semen Flavonoids During Biotransformation and Their Effect on Human Gut Microbiota In Vitro. | Foods | 2026 | https://conductscience.org/library/papers/42737321 | PubMed |
| 42655074 | Low Prevalence and Abundance of Akkermansia in Older Japanese Adults: Inverse Association with a Noodle-Based Dietary Pattern but Not with Physical Function. | Microorganisms | 2026 | https://conductscience.org/library/papers/42655074 | PubMed |
| 42653741 | Sulforaphane and Broccoli-Derived Preparations in Obesity and Obesity-Related Metabolic Dysfunction: Mechanistic Insights, Preclinical Evidence, and Clinical Perspectives. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42653741 | PubMed |
| 42625898 | Unveiling functional heterogeneity in pasteurized Akkermansia muciniphila identifies AKK2645 as a superior postbiotic for metabolic syndrome. | Front Nutr | 2026 | https://conductscience.org/library/papers/42625898 | PubMed |
| 42625202 | Diet-dependent gut microbiota remodeling by pasteurized Akkermansia muciniphila, specialized pro-resolving mediators, and B vitamins in mice. | J Transl Med | 2026 | https://conductscience.org/library/papers/42625202 | PubMed |
| 42606020 | An Intravesical Akkermansia muciniphila-Based Chemo-Immunotherapeutic Platform for Bladder Cancer. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42606020 | PubMed |
| 42568645 | Epithelial model-dependent host-microbe interactions in human intestinal models under anaerobic Transwell co-culture. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42568645 | PubMed |
| 42533336 | Metabolic disorder-MASLD-cardiovascular disease-kidney disease (MMCK) syndrome: an expansion of the Cardiovascular-Kidney-Metabolic (CKM) framework. | Cardiovasc Diabetol Endocrinol Rep | 2026 | https://conductscience.org/library/papers/42533336 | PubMed |
| 42528156 | Decoding Akkermansia muciniphila Effector Biology: From Microbial Molecules to Host Outcomes. | Microbiologyopen | 2026 | https://conductscience.org/library/papers/42528156 | PubMed |
| 42454935 | Integrated multi-omics analysis reveals gut microbiota-associated placental metabolic and transcriptomic alterations in placenta previa. | mSystems | 2026 | https://conductscience.org/library/papers/42454935 | PubMed |
| 42365402 | Therapeutic efficacy of Jichuan decoction in slow-transit constipation: focus on gut microbiota modulation. | J Tradit Chin Med | 2026 | https://conductscience.org/library/papers/42365402 | PubMed |
| 42294227 | Liraglutide and Dapagliflozin Synergistically Reshape Gut Microbiota and Metabolic Profiles to Ameliorate Type‑2 Diabetes in Mice. | ACS Omega | 2026 | https://conductscience.org/library/papers/42294227 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39192579
GET https://conductscience.org/api/papers/v1/39192579/references?page=2